1330 related articles for article (PubMed ID: 33710626)
21. Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants.
Askie LM; Darlow BA; Davis PG; Finer N; Stenson B; Vento M; Whyte R
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011190. PubMed ID: 28398697
[TBL] [Abstract][Full Text] [Related]
22. Early full enteral feeding for preterm or low birth weight infants.
Walsh V; Brown JVE; Copperthwaite BR; Oddie SJ; McGuire W
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013542. PubMed ID: 33368149
[TBL] [Abstract][Full Text] [Related]
23. Synbiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.
Sharif S; Heath PT; Oddie SJ; McGuire W
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD014067. PubMed ID: 35230697
[TBL] [Abstract][Full Text] [Related]
24. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
[TBL] [Abstract][Full Text] [Related]
25. Continuous nasogastric milk feeding versus intermittent bolus milk feeding for preterm infants less than 1500 grams.
Sadrudin Premji S; Chessell L; Stewart F
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD001819. PubMed ID: 34165778
[TBL] [Abstract][Full Text] [Related]
26. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; van de Loo M; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010941. PubMed ID: 36912887
[TBL] [Abstract][Full Text] [Related]
27. Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.
Aher SM; Ohlsson A
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD004868. PubMed ID: 30776084
[TBL] [Abstract][Full Text] [Related]
28. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
[TBL] [Abstract][Full Text] [Related]
29. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.
Walters A; McKinlay C; Middleton P; Harding JE; Crowther CA
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD003935. PubMed ID: 35377461
[TBL] [Abstract][Full Text] [Related]
30. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.
Sharif S; Meader N; Oddie SJ; Rojas-Reyes MX; McGuire W
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD005496. PubMed ID: 37493095
[TBL] [Abstract][Full Text] [Related]
31. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.
Subramaniam P; Ho JJ; Davis PG
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278
[TBL] [Abstract][Full Text] [Related]
33. Formula versus donor breast milk for feeding preterm or low birth weight infants.
Quigley M; Embleton ND; McGuire W
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD002971. PubMed ID: 31322731
[TBL] [Abstract][Full Text] [Related]
34. Short versus long feeding interval for bolus feedings in very preterm infants.
Ibrahim NR; Van Rostenberghe H; Ho JJ; Nasir A
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD012322. PubMed ID: 34415568
[TBL] [Abstract][Full Text] [Related]
35. Comparison of different protein concentrations of human milk fortifier for promoting growth and neurological development in preterm infants.
Gao C; Miller J; Collins CT; Rumbold AR
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD007090. PubMed ID: 33215474
[TBL] [Abstract][Full Text] [Related]
36. Re-feeding versus discarding gastric residuals to improve growth in preterm infants.
Abiramalatha T; Thanigainathan S; Ramaswamy VV; Rajaiah B; Ramakrishnan S
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD012940. PubMed ID: 37387544
[TBL] [Abstract][Full Text] [Related]
37. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
Bruschettini M; Brattström P; Russo C; Onland W; Davis PG; Soll R
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013873. PubMed ID: 37040532
[TBL] [Abstract][Full Text] [Related]
38. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
[TBL] [Abstract][Full Text] [Related]
39. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; De Jaegere AP; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
[TBL] [Abstract][Full Text] [Related]
40. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]